These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3319642)

  • 1. High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy.
    Taylor WB; Simpson JM; Bateman DN
    Eur J Clin Pharmacol; 1987; 33(2):161-5. PubMed ID: 3319642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
    O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
    Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.
    Allan SG; Cornbleet MA; Lockhart SP; Warrington PS; Leonard RC; Smyth JF
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1481-4. PubMed ID: 6389147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.
    Anthony LB; Krozely MG; Woodward NJ; Hainsworth JD; Hande KR; Brenner DE; Greco FA; Burish TG
    J Clin Oncol; 1986 Jan; 4(1):98-103. PubMed ID: 3510285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
    Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
    Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
    Sorbe B; Hallén C; Skåre NG; Underskog I
    Radiother Oncol; 1989 Jun; 15(2):161-7. PubMed ID: 2762589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
    Wilder-Smith C; Schimke J; Vergin H; Senn HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1464-7. PubMed ID: 2619781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy.
    Ibrahim EM; Al-Idrissi HY; Ibrahim A; Absood G; Al-Dossary E; Al-Jammaa A; Al-Ethan S; Eliopoulos A
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):283-8. PubMed ID: 3519233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine.
    al-Idrissi HY; Ibrahim EM; Abdullah KA; Ababtain WA; Boukhary HA; Macaulay HM
    Br J Cancer; 1988 Mar; 57(3):308-12. PubMed ID: 3281702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
    Seng KT; Tiong CE; Hiang TC
    Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betamethasone-dixyrazine versus metoclopramide as antiemetic treatment in cancer chemotherapy.
    Sorbe B; Hallén C
    Acta Oncol; 1988; 27(4):357-60. PubMed ID: 3060151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
    Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
    Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Gilbert CJ; Ohly KV; Rosner G; Peters WP
    Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
    Heim ME; Queisser W; Altenburg HP
    Cancer Chemother Pharmacol; 1984; 13(2):123-5. PubMed ID: 6467496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
    Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
    Saller R; Hellenbrecht D; Bühring M; Hess H
    J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.